SEC Form 4 · accession 0001372514-26-000065
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian M. Strem
Officer — President and CEO · Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 2, 2026 · 4:46 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001372514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2026 | F | 1,869 | $2.66 | D | 58,823 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Net Share settlement, shares withheld for employee tax obligation upon vesting of restricted stock.